{rfName}
Te

License and use

Citations

Share
Intellectual Property
>
Patent

Tetrahydro-spiroindoline-pyrrolopyrrole-triones inhibitors of the NRF2-BETA-TRCP interaction for use in the treatment of fatty liver disease

Publicated to:Universidad Autónoma de Madrid; Universidad Miguel Hernández de Elche; FUNDACIÓN DE INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO DE LA PRINCESA - 2022-01-13 (), DOI: EP22701338

Cuadrado Pastor, Antonio; Leon Martinez, Rafael; Fernandez Gines, Raquel; Franco Gonzalez, Juan Felipe; Garcia Lopez, Manuela; Rojo Sanchís, Ana Isabel;

Affiliations

Abstract

Keywords

Quality index

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: Last Author (ROJO SANCHIS, ANA ISABEL).